Paper Details

  1. Home
  2. Paper Details

Double bronchodilation in chronic obstructive pulmonary disease: a crude analysis from a systematic review.

Author: Abad ArranzMaria, Calero-AcuñaCarmen, Carrasco-HernándezLaura, Lopez-CamposJose Luis, Márquez-MartínEduardo, Ortega RuizFrancisco, Quintana GallegoEsther

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This systematic review examines the efficacy of double bronchodilation, combining a long-acting muscarinic antagonist (LAMA) and a long-acting β2-agonist (LABA) in a single inhaler, for the treatment of COPD. The review focuses on comparing this treatment approach to placebo and monotherapy bronchodilation.
Paper Details　
Original Abstract of the Article :
Label="OBJECTIVE" NlmCategory="OBJECTIVE">The combination of a long-acting muscarinic antagonist (LAMA) and a long-acting &#946;<sub>2</sub>-agonist (LABA) in a single inhaler is a viable treatment option for patients with chronic obstructive pulmonary disease (COPD). Here, we systematically review ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491571/

データ提供：米国国立医学図書館（NLM）

Double Bronchodilation in COPD: A Comprehensive Look

This systematic review delves into the efficacy of double bronchodilation, a combination therapy using long-acting muscarinic antagonists (LAMAs) and long-acting beta2-agonists (LABAs), for managing chronic obstructive pulmonary disease (COPD). The study focuses on evaluating the effectiveness of double bronchodilation compared to placebo and monotherapy, meticulously analyzing existing research to provide a comprehensive understanding of this treatment strategy.

A Breath of Fresh Air for COPD Patients

The findings suggest that double bronchodilation might offer a significant benefit to patients with COPD, providing improved lung function and potentially enhancing their quality of life. However, further research is needed to fully understand the long-term effects and optimize the application of this treatment approach.

Navigating the Desert of COPD

This research is like a refreshing spring in the arid landscape of COPD. By providing a deeper understanding of double bronchodilation, it empowers healthcare professionals to make more informed decisions and provide patients with the best possible care. This journey toward better treatment options is an ongoing quest for relief and improved quality of life for individuals living with COPD.

Dr.Camel's Conclusion

This review, like a desert oasis, offers a comprehensive overview of double bronchodilation for COPD. It highlights the potential benefits of this approach, emphasizing the importance of continued research to refine treatment strategies and improve the lives of those living with this chronic condition.

Date :
  1. Date Completed 2018-04-24
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28694697

DOI: Digital Object Identifier

PMC5491571

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.